Canada Life
KZIA

Canada Life’s Kazia Therapeutics KZIA Stock Holding History

Canada Life’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-6
Closed -$5K – 2516
2015
Q2 		$5K Buy
+6
New +$6.81K ﹤0.01% 2577

Other funds holding KZIA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MWP
MYCIO Wealth Partners Philadelphia, Pennsylvania $502M AUM 11.65% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Canada Life's KZIA Position: Q3 2015 in Review

Canada Life sold out of Kazia Therapeutics (KZIA) in Q3 2015, closing a stake of 6 shares — an estimated $5K sold.

Canada Life first reported a position in KZIA in Q2 2015 and held it in 1 quarter. The position peaked at $5K in Q2 2015. 7 funds tracked by Wall St. Rank hold KZIA as of Q3 2015.

  • Canada Life reported no remaining Kazia Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Canada Life sold 6 Kazia Therapeutics shares in Q3 2015, an estimated $5K.
  • Canada Life first reported a position in Kazia Therapeutics in Q2 2015 and held it in 1 quarter.
  • Canada Life's Kazia Therapeutics position peaked at $5K in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q3 2015.

Based on Canada Life's 13F filing for Q3 2015, filed 10 Nov 2015.